AIM: To analyze the clinical efficacy of phakic posterior chamber implantable contact lens(ICL)implantation on high myopia patients.

METHODS: Thirty-four patients(68 eyes)who checked and diagnosed as high myopia in our hospital from June 2014 to June 2015 were selected as the clinical research subjects, and all the patients were given phakic posterior chamber intraocular lens implantation treatment. The diopter, visual acuity recovery, central anterior chamber depth, corneal endothelial cell count, and intraocular pressure after treatment were observed.

RESULTS: The equivalent spherical refraction, central anterior chamber depth, uncorrected visual acuity and best corrected visual acuity recovery at 1, 3 and 6mo, 1 and 2a after treatment were better than those before treatment, and the differences were statistically significant(P<0.05). There were no significant differences in corneal endothelial cell count and intraocular pressure at 1, 3 and 6mo, 1 and 2a after treatment compared with those before treatment(P>0.05). There were no significant differences in uncorrected visual acuity, best corrected visual acuity, equivalent spherical refraction and central anterior chamber depth at 1, 3mo and 1 and 2a after treatment(P>0.05).

CONCLUSION: The application of phakic posterior chamber intraocular lens implantation for the treatment of high myopia patients can improve the equivalent spherical refraction and central anterior chamber depth, improve uncorrected visual acuity, meanwhile, it has less effect on the patient's intraocular pressure and corneal endometrial cells, the effect maintenance and safety is better which meet their expectations.